Fred Alger Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fred Alger Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-264,990	Closed	-$21.1M	–	577
2022 Q2	$21.1M	Sell	264,990 -63,452	-19%	-$6.01M	0.1%	170
2022 Q1	$34.6M	Sell	328,442 -244,064	-43%	-$23.8M	0.11%	162
2021 Q4	$61.7M	Sell	572,506 -61,405	-10%	-$6.7M	0.15%	147
2021 Q3	$69.4M	Buy	633,911 +77,228	+14%	+$8.02M	0.17%	139
2021 Q2	$52.1M	Buy	556,683 +59,558	+12%	+$5.48M	0.12%	162
2021 Q1	$45.8M	Sell	497,125 -261,971	-35%	-$22.1M	0.12%	166
2020 Q4	$55.5M	Sell	759,096 -55,676	-7%	-$4.14M	0.14%	141
2020 Q3	$63.3M	Buy	814,772 +739,936	+989%	+$50.9M	0.18%	123
2020 Q2	$4.16M	Buy	74,836 +64,836	+648%	+$2.77M	0.01%	245
2020 Q1	$296K	Buy	10,000 +7,000	+233%	+$237K	﹤0.01%	383
2019 Q4	$109K	Buy	+3,000	New	+$92K	﹤0.01%	415
2019 Q3	–	Sell	-20,000	Closed	-$481K	–	567
2019 Q2	$481K	Buy	+20,000	New	+$507K	﹤0.01%	383
2014 Q4	–	Sell	-432,217	Closed	-$5.31M	–	632
2014 Q3	$5.31M	Sell	432,217 -131,682	-23%	-$1.53M	0.03%	336
2014 Q2	$8.92M	Sell	563,899 -398,441	-41%	-$5.69M	0.04%	307
2014 Q1	$14.6M	Buy	+962,340	New	+$10.9M	0.07%	259

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Fred Alger Management's HZNP Position: Q3 2022 in Review

Fred Alger Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 264,990 shares — an estimated $21.1M sold.

Fred Alger Management first reported a position in HZNP in Q1 2014 and held it in 15 quarters. The position peaked at $69.4M in Q3 2021. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Fred Alger Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Fred Alger Management sold 264,990 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $21.1M.
Fred Alger Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 15 quarters.
Fred Alger Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $69.4M in Q3 2021.
529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Fred Alger Management's 13F filing for Q3 2022, filed 15 Nov 2022.